The AHA yesterday announced support for the Opioid Workforce Act of 2019, bipartisan legislation to reduce the nation’s shortage of opioid treatment providers by increasing the number of resident physician slots in hospitals with programs focused on substance use disorder treatment. “Your legislation would address existing shortages by adding 1,000 Medicare-funded training positions in approved residency programs in addiction medicine, addiction psychiatry or pain management,” AHA said in a letter to Rep. Brad Schneider, D-Ill., the bill’s author. “These new slots would constitute a major step toward increasing access to SUD treatment for communities in need.” Schneider is joined in introducing the legislation by Reps. Susan Brooks, R-Ind., Ann Kuster, D-N.H., and Elise Stefanik, R-N.Y.

Related News Articles

Headline
AHA Sept. 20 urged leaders of the Senate Health, Education, Labor and Pensions Committee to remove from the Bipartisan Primary Care and Health Workforce…
Headline
Certain policy decisions and challenges in implementing the No Surprises Act have undermined the unbiased and timely process Congress intended and contributed…
Headline
The AHA and American Medical Association Sept. 18 urged the U.S. Court of Appeals for the 5th Circuit to affirm a district court decision that invalidated a No…
Headline
Sens. Joe Manchin, D-W.Va., and Marco Rubio, R-Fla., Sept. 12 introduced the Safety from Violence for Healthcare Employees Act, AHA-supported legislation that…
Headline
Republicans on the House Energy and Commerce, Ways and Means, and Education & Workforce Committees have released a summary of draft legislation the…
Headline
In a letter Aug. 1 to House and Senate sponsors, the AHA and 48 other national associations voiced strong support for the Conrad State 30 and Physician…